BETHESDA, Md., Nov. 24, 2014 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property, today provided an update regarding Spherix v. VTech Telecommunications Ltd., Case No. 3:13-cv-03494-M and Spherix v. Uniden Corporation et al., Case No. 3:13-cv-03496-M, both in the United States District Court for the Northern District of Texas.

Spherix Logo

On November 21, 2014 the Markman hearing for the Company's cases against VTech and Uniden was conducted as scheduled.

Anthony Hayes, Chief Executive Officer of Spherix, stated, "We completed another key step in our cases against VTech and Uniden last Friday with the completion of the Markman hearing. We are pleased with the efforts put forth by our legal team to pursue enforcement of our intellectual property rights and now await the Court's decision."

Markman hearings are an opportunity to address the Court by oral argument.  Each side argues to the judge its respective position on how the key claim terms within a patent should be construed.  At some point following the Markman hearing, the Court will issue a ruling on the construction of the key terms for later use by the jury.  

About Spherix

Spherix Incorporated was launched in 1967 as a scientific research company. Spherix is committed to advancing innovation by active participation in the patent market. Spherix draws on portfolios of pioneering technology patents to partner with and support product innovation.

Forward-Looking Statements

Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contact:

Investor Relations:

Hayden IR


Brett Mass, Managing Partner


Phone: (646) 536-7331


Email: brett@haydenir.com


www.haydenir.com



Spherix:

Phone: (703) 992-9325


Email: info@spherix.com


www.spherix.com

Logo - http://photos.prnewswire.com/prnh/20131104/PH08853LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/markman-hearing-held-as-scheduled-in-vtech-and-uniden-cases-300000044.html

SOURCE Spherix Incorporated

Copyright 2014 PR Newswire

Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Alkido Pharma Charts.
Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Alkido Pharma Charts.